policy

ACAP Research Prescription Drugs

Analysis of Dual Eligible Pharmacy Costs Under Medicaid and Medicare Part D

, , , , 

Lewin Group and ACAP. “Analysis of Dual Eligible Pharmacy Costs Under Medicaid and Medicare Part D.” September 2008.

View the full article »

Related Articles

Plan Resource Medicare and MLTSS

Coding Intensity Options: The Perspective of Safety Net Health Plans

October 1, 2024
Medicare and MLTSS

ACAP Comments on CMS Request for Information on Medicare Advantage Data

May 29, 2024
Comment Letter Medicare and MLTSS

Sign On Letter- 2025 Advance Notice

April 5, 2024
Comment Letter Medicare and MLTSS

ACAP Comments on CY 2025 Medicare Advantage and Prescription Drug Plan Proposed Rule

January 5, 2024
ACAP Research Marketplaces

Overlap Issuers: Possible Drivers of Premium Reductions: June 2020

June 25, 2020
Comment Letter Prescription Drugs

PQA Comment Letter: Medicare and Medicaid Programs Contract Year 2021 and 2022

April 15, 2020